These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

743 related items for PubMed ID: 24962900

  • 1. Quantitative evaluation of CT-perfusion map as indicator of tumor response to transarterial chemoembolization and radiofrequency ablation in HCC patients.
    Ippolito D, Fior D, Bonaffini PA, Capraro C, Leni D, Corso R, Sironi S.
    Eur J Radiol; 2014 Sep; 83(9):1665-71. PubMed ID: 24962900
    [Abstract] [Full Text] [Related]

  • 2. Viable residual tumor tissue after radiofrequency ablation treatment in hepatocellular carcinoma: evaluation with CT perfusion.
    Ippolito D, Bonaffini PA, Capraro C, Leni D, Corso R, Sironi S.
    Abdom Imaging; 2013 Jun; 38(3):502-10. PubMed ID: 22743839
    [Abstract] [Full Text] [Related]

  • 3. Hepatocellular carcinoma treated with transarterial chemoembolization: dynamic perfusion-CT in the assessment of residual tumor.
    Ippolito D, Bonaffini PA, Ratti L, Antolini L, Corso R, Fazio F, Sironi S.
    World J Gastroenterol; 2010 Dec 21; 16(47):5993-6000. PubMed ID: 21157976
    [Abstract] [Full Text] [Related]

  • 4. Dynamic Contrast-Enhanced Magnetic Resonance Imaging With Gadolinium Ethoxybenzyl Diethylenetriamine Pentaacetic Acid for Quantitative Assessment of Vascular Effects on Hepatocellular-Carcinoma Lesions Treated by Transarterial Chemoembolization or Radiofrequency Ablation.
    Ippolito D, Trattenero C, Talei Franzesi C, Casiraghi A, Lombardi S, Vacirca F, Corso R, Sironi S.
    J Comput Assist Tomogr; 2016 Dec 21; 40(5):692-700. PubMed ID: 27560010
    [Abstract] [Full Text] [Related]

  • 5. Tumour-related neoangiogenesis: functional dynamic perfusion computed tomography for diagnosis and treatment efficacy assessment in hepatocellular carcinoma.
    Ippolito D, Fior D, Franzesi CT, Capraro C, Casiraghi A, Leni D, Vacirca F, Corso R, Sironi S.
    Dig Liver Dis; 2014 Oct 21; 46(10):916-22. PubMed ID: 25023006
    [Abstract] [Full Text] [Related]

  • 6. Perfusion CT in cirrhotic patients with early stage hepatocellular carcinoma: assessment of tumor-related vascularization.
    Ippolito D, Sironi S, Pozzi M, Antolini L, Invernizzi F, Ratti L, Leone EB, Fazio F.
    Eur J Radiol; 2010 Jan 21; 73(1):148-52. PubMed ID: 19054640
    [Abstract] [Full Text] [Related]

  • 7. Comparison of volume perfusion computed tomography and contrast-enhanced ultrasound for assessment of therapeutic effect of transarterial chemoembolization in patients with hepatocellular carcinoma: a preliminary report.
    Kaufmann S, Schulze M, Spira D, Horger M.
    Acta Radiol; 2016 Jan 21; 57(1):8-12. PubMed ID: 25585848
    [Abstract] [Full Text] [Related]

  • 8. Computed tomography perfusion in evaluating the therapeutic effect of transarterial chemoembolization for hepatocellular carcinoma.
    Chen G, Ma DQ, He W, Zhang BF, Zhao LQ.
    World J Gastroenterol; 2008 Oct 07; 14(37):5738-43. PubMed ID: 18837093
    [Abstract] [Full Text] [Related]

  • 9. Hepatocellular carcinoma in cirrhotic liver disease: functional computed tomography with perfusion imaging in the assessment of tumor vascularization.
    Ippolito D, Sironi S, Pozzi M, Antolini L, Ratti L, Alberzoni C, Leone EB, Meloni F, Valsecchi MG, Fazio F.
    Acad Radiol; 2008 Jul 07; 15(7):919-27. PubMed ID: 18572129
    [Abstract] [Full Text] [Related]

  • 10. [Diagnostic value of computed tomographic perfusion imaging of whole liver for quantitative assessment of blood flow state in liver cancer after transcatheter arterial chemoembolization].
    Li SM, Gao ZL, Lyu XT, Jia J, Zhu P, Chen Y, Liu YL, Zhang ZX.
    Zhonghua Gan Zang Bing Za Zhi; 2018 Jun 20; 26(6):429-435. PubMed ID: 30317756
    [Abstract] [Full Text] [Related]

  • 11. Computed Tomography Perfusion Following Transarterial Chemoembolization of Hepatocellular Carcinoma: A Feasibility Study in the Early Period.
    Wimmer T, Steiner J, Talakic E, Stauber R, Quehenberger F, Portugaller RH, Schoellnast H.
    J Comput Assist Tomogr; 2017 Jun 20; 41(5):708-712. PubMed ID: 28296685
    [Abstract] [Full Text] [Related]

  • 12. Volume perfusion computed tomography (VPCT)-based evaluation of response to TACE using two different sized drug eluting beads in patients with nonresectable hepatocellular carcinoma: Impact on tumor and liver parenchymal vascularisation.
    Kaufmann S, Horger T, Oelker A, Beck S, Schulze M, Nikolaou K, Ketelsen D, Horger M.
    Eur J Radiol; 2015 Dec 20; 84(12):2548-54. PubMed ID: 26428842
    [Abstract] [Full Text] [Related]

  • 13. Viable hepatocellular carcinoma around retained iodized oil after transarterial chemoembolization: radiofrequency ablation of viable tumor plus retained iodized oil versus viable tumor alone.
    Kim JH, Kim PN, Won HJ, Shin YM.
    AJR Am J Roentgenol; 2014 Nov 20; 203(5):1127-31. PubMed ID: 25341154
    [Abstract] [Full Text] [Related]

  • 14. Use of contrast-enhanced ultrasonography with a perflubutane-based contrast agent performed one day after transarterial chemoembolization for the early assessment of residual viable hepatocellular carcinoma.
    Takizawa K, Numata K, Morimoto M, Kondo M, Nozaki A, Moriya S, Ishii T, Oshima T, Fukuda H, Okada M, Takebayashi S, Maeda S, Tanaka K.
    Eur J Radiol; 2013 Sep 20; 82(9):1471-80. PubMed ID: 23769188
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of Texture Analysis Parameter for Response Prediction in Patients with Hepatocellular Carcinoma Undergoing Drug-eluting Bead Transarterial Chemoembolization (DEB-TACE) Using Biphasic Contrast-enhanced CT Image Data: Correlation with Liver Perfusion CT.
    Kloth C, Thaiss WM, Kärgel R, Grimmer R, Fritz J, Ioanoviciu SD, Ketelsen D, Nikolaou K, Horger M.
    Acad Radiol; 2017 Nov 20; 24(11):1352-1363. PubMed ID: 28652049
    [Abstract] [Full Text] [Related]

  • 16. [Transarterial chemoembolization plus computed tomography-guided percutaneous radiofrequency ablation for small hepatocellular carcinoma in special locations].
    Guo YJ, Huang WS, Zhou B, Chen JW, Cai MY, Qian JS, Huang MS, Shan H, Zhu KS.
    Zhonghua Yi Xue Za Zhi; 2013 Sep 03; 93(33):2627-30. PubMed ID: 24360041
    [Abstract] [Full Text] [Related]

  • 17. Hypertonic saline-enhanced radiofrequency versus chemoembolization sequential radiofrequency in the treatment of large hepatocellular carcinoma.
    El-Kady NM, Esmat G, Mahmoud EH, Darweesh SK, Mahmoud SH, Elagawy WA.
    Eur J Gastroenterol Hepatol; 2013 May 03; 25(5):628-33. PubMed ID: 23325283
    [Abstract] [Full Text] [Related]

  • 18. Parenchymal Liver Blood Volume and Dynamic Volume Perfusion CT Measurements of Hepatocellular Carcinoma in Patients Undergoing Transarterial Chemoembolization.
    Rathmann N, Kara K, Budjan J, Henzler T, Smakic A, Schoenberg SO, Diehl SJ.
    Anticancer Res; 2017 Oct 03; 37(10):5681-5685. PubMed ID: 28982886
    [Abstract] [Full Text] [Related]

  • 19. Early Response of Hepatocellular Carcinoma to Chemoembolization: Volume Computed Tomography Liver Perfusion Imaging as a Short-Term Response Predictor.
    Su TH, He W, Jin L, Chen G, Xiao GW.
    J Comput Assist Tomogr; 2017 Oct 03; 41(2):315-320. PubMed ID: 27801695
    [Abstract] [Full Text] [Related]

  • 20. CT Perfusion for Early Response Evaluation of Radiofrequency Ablation of Focal Liver Lesions: First Experience.
    Marquez HP, Puippe G, Mathew RP, Alkadhi H, Pfammatter T, Fischer MA.
    Cardiovasc Intervent Radiol; 2017 Jan 03; 40(1):90-98. PubMed ID: 27812781
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.